Gastrointestinal smooth muscle calcium influx pathway

The gastrointestinal (GI) smooth muscle calcium influx pathway is a physiological process that regulates the contraction and motility of the digestive tract (3.1.1, 3.1.3). This pathway primarily involves the entry of extracellular calcium ions into smooth muscle cells through voltage-gated L-type calcium channels, specifically the Cav1.2 subtype, in response to membrane depolarization (3.4.1, 3.4.3). The resulting increase in intracellular calcium activates the contractile machinery via the calmodulin-myosin light chain kinase (MLCK) system, leading to muscle contraction (3.1.1). Dysregulation of this pathway, such as excessive calcium influx, is a key factor in the pathophysiology of functional GI disorders like irritable bowel syndrome (IBS), where it contributes to spasms and abdominal pain (3.2.2, 3.3.5). Pharmacological agents known as GI-selective calcium antagonists, such as pinaverium bromide and otilonium bromide, target this pathway by blocking L-type calcium channels (3.2.1, 3.3.3). These drugs are often designed with low systemic absorption to concentrate their effects within the GI tract, thereby minimizing systemic cardiovascular side effects (3.3.1, 3.3.2).

Other names

Gastrointestinal calcium influxIntestinal smooth muscle calcium entryGastrointestinal calcium channel pathwayGI smooth muscle calcium signaling

Inhibition of extracellular calcium influx into gastrointestinal smooth muscle cells by blocking voltage-gated L-type calcium channels, thereby preventing excessive muscle contraction and spasms (3.2.2, 3.3.3).